Form 483

US Compounding Inc Form 483, 2014-03-27

FDA issued a Form 483 to US Compounding Inc on 2014-03-27 with 8 public-safe observations.

483· Form 483 issuedHuman Drugs8 observations

US Compounding Inc · Conway, United States · Issued March 27, 2014

Overview

  • 8 public-safe observations are available for this inspection.
  • 8 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

27 Mar 2014
21 CFR 211.28(a)

Protective Apparel Not Worn

Cited by Erika V Butler, Kimberley A Hoefen

27 Mar 2014
21 CFR 211.42(c)(10)(v)

Cleaning System

Cited by Erika V Butler, Kimberley A Hoefen

27 Mar 2014
21 CFR 211.56(a)

Sanitation--buildings not clean, free of infestation

Cited by Erika V Butler, Kimberley A Hoefen

27 Mar 2014
21 CFR 211.67(a)

Cleaning / Sanitizing / Maintenance

Cited by Erika V Butler, Kimberley A Hoefen

27 Mar 2014
21 CFR 211.94(b)

Protection from external factors

Cited by Erika V Butler, Kimberley A Hoefen

Inspected site

UCUS Compounding IncConway, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.113(b)Cited across public-safe Form 483 observations1x
21 CFR 211.165(a)Cited across public-safe Form 483 observations1x
21 CFR 211.167(a)Cited across public-safe Form 483 observations1x
21 CFR 211.28(a)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(10)(v)Cited across public-safe Form 483 observations1x
21 CFR 211.56(a)Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x
21 CFR 211.94(b)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 8 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere